SCHEMBL30320491

SCHEMBL30320491

Nc1ccc(-c2nn(C3CCN(C4COC4)CC3)c3ncnc(N)c23)cc1F

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 19/20 0.61
▸ PIK3CA P42336 19/20 0.61
▸ PIK3CB P42338 19/20 0.61
▸ PIK3CG P48736 19/20 0.61
▸ PRKDC P78527 19/20 0.61
▸ ABL1 P00519 18/20 0.61
▸ EGFR P00533 18/20 0.61
▸ HCK P08631 18/20 0.61
▸ SRC P12931 18/20 0.61
▸ KDR P35968 18/20 0.61
▸ MTOR P42345 18/20 0.61
▸ EPHB4 P54760 17/20 0.61
▸ PI4KB Q9UBF8 14/20 0.61
▸ IGF1R P08069 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24096501 1.00 PIK3CD (0.61) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL24096492 0.91 PIK3CD (0.66) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL29780871 0.91 PIK3CD (0.66) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23997153 0.90 PIK3CD (0.68) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL29998830 0.88 PIK3CD (0.69) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL24096758 0.88 PIK3CD (0.69) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30320505 0.87 KDR (0.79) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL24096623 0.87 KDR (0.79) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL24096741 0.87 PIK3CD (0.57) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL24096530 0.86 SRC (0.66) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116075513-A Inhibitors of NEK7 kinase 哈利亚治疗公司 2023-05-05 — — CN disclosed
EP-4161933-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. (US) 2023-04-12 — — EP disclosed
Send feedback